Annovis Bio Inc. (ANVS) Social Stream
ANNOVIS BIO INC (ANVS) Price Targets From Analysts
The tables below show price targets and recommendations from analysts covering ANNOVIS BIO INC.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2021-10-22 | 1 | $70 | $70 | $70 | $7.39 | 847.23% |
| 2022-04-08 | 1 | $26 | $26 | $26 | $7.39 | 251.83% |
| 2022-08-09 | 2 | $37 | $26 | $31.5 | $7.39 | 326.25% |
| 2023-04-04 | 3 | $72 | $26 | $46 | $7.39 | 522.46% |
| 2023-10-13 | 2 | $72 | $40 | $56 | $7.39 | 657.78% |
| 2023-10-20 | 3 | $72 | $26.001 | $46 | $7.39 | 522.46% |
| 2023-11-13 | 4 | $72 | $26.001 | $40.75 | $7.39 | 451.42% |
Price Target Last Issued April 8, 2022
The Trend in the Analyst Price Target
ANVS's average price target has moved down $15.25 over the prior 138 days.
Over the past 41 weeks, ANVS's average upside potential has been 357.24%.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Share Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2023-04-21 | 2 | 72 | 40.000 | 56 | 15.81 | 254.21% |
| 2023-05-12 | 2 | 72 | 40.000 | 56 | 14.09 | 297.44% |
| 2023-06-28 | 2 | 72 | 40.000 | 56 | 14.16 | 295.48% |
| 2023-10-13 | 2 | 72 | 40.000 | 56 | 7.86 | 612.47% |
| 2023-10-20 | 4 | 72 | 26.001 | 46 | 8.58 | 436.13% |
ANVS Broker Recommendations Summary
| Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
|---|---|---|---|---|---|---|
| 1 | 4 | 0 | 0 | 0 | 0 | 4 |
The Trend in the Broker Recommendations
Over the past 40 months, ANVS's average broker recommendation rating improved by 0.
The points below can provide you with additional insight regarding what the price target and recommendations metrics in the table above mean for investors.
- In terms of how ANNOVIS BIO INC fares relative to all US stocks, note that its number of analysts covering the stock is greater than 58.72% of that group.
- ANVS has a higher upside potential (average analyst target price relative to current price) than 917.87% of all US stocks.
- ANNOVIS BIO INC's variance in analysts' estimates is lower than -428.61% of all US stocks.
- ANNOVIS BIO INC's average analyst price target is greater than 843.57% of stocks in the small market cap category.
Stocks similar to ANNOVIS BIO INC in the Pharmaceutical Products industry regarding analyst recommendations and price targets are ETNB, GRTX, and RAPT.
View All Top Stocks by Price Target
Is ANVS a Buy, Hold or Sell? See the POWR Ratings now!